Skip to main content

FDA Approves New Drug for Pancreatic Cancer

A new pancreatic cancer therapy from Merrimack Pharmaceutical Inc. was approved by the Food and Drug Administration, marking the company's first drug to get regulatory clearance.

Republish
Lead image for this article

A new pancreatic cancer therapy from Merrimack Pharmaceutical Inc. was approved by the Food and Drug Administration, marking the company's first drug to get regulatory clearance. The drug – Onivyde – will carry a “black box’’ warning and is not approved for use as a single agent to fight pancreatic cancer, which is considered the “deadliest’’ cancer and accounts for 7 percent of cancer deaths. (Reuters)

Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Support independent Texas news

Become a member. Join today.

Choose an amount or learn more about membership.

$20 $25 $50 Other
Donate now

Information about the authors

Madlin Mekelburg’s staff photo

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics